Clinics

• Latest
• Best
• Search…

• Clinics · Jan 2024

  Qiliqiangxin capsule alleviates cardiac hypertrophy and cardiac dysfunction by regulating miR-382-5p/ATF3 axis.

  Qiliqiangxin Capsule (QL) was investigated for its possible role in cardiac hypertrophy in this study. ⋯ QL may alleviate cardiac hypertrophy and cardiac dysfunction via the miR-382-5p/ATF3 axis.

  expand abstract… or not…

• Clinics · Jan 2024

  Letter Case Reports

  NXP-2 positive dermatomyositis with marked dysphagia following an insect bite.

  no abstract available

  keep reading… or not…

• Clinics · Jan 2024

  Assessing the impact of implementing the clinical protocol and therapeutic guidelines in COPD in real-life.

  no abstract available

  read more… or not…

• Clinics · Jan 2024

  Letter Case Reports

  Transient, self-limiting, antibody-negative myositis with venetoclax.

  no abstract available

  read more… or not…

• Clinics · Jan 2024

  Letter Case Reports

  Takotsubo syndrome is triggered by hypoactive delirium and recognized by increased catecholamine requirement in the ICU.

  no abstract available

  expand abstract… mark as read…